NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 123 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $27,195 | -95.2% | 10,500 | -90.8% | 0.00% | -100.0% |
| Q4 2022 | $570,272 | -94.6% | 113,600 | -86.0% | 0.00% | -90.5% |
| Q3 2022 | $10,613,334 | +2.9% | 811,366 | +0.8% | 0.02% | +10.5% |
| Q2 2022 | $10,318,319 | -17.5% | 804,886 | -1.9% | 0.02% | +5.6% |
| Q1 2022 | $12,513,587 | +72.2% | 820,536 | +100.0% | 0.02% | -5.3% |
| Q4 2021 | $7,266,000 | -14.7% | 410,264 | +1.2% | 0.02% | -20.8% |
| Q3 2021 | $8,521,000 | -26.1% | 405,367 | -30.7% | 0.02% | +41.2% |
| Q2 2021 | $11,534,000 | – | 584,882 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 18,136,735 | $237,228,000 | 52.50% |
| Ponoi II Management, LLC | 1,298,908 | $16,990,000 | 44.41% |
| Ponoi Management, LLC | 1,298,908 | $16,990,000 | 23.20% |
| Euclidean Capital LLC | 746,674 | $9,766,000 | 9.07% |
| StepStone Group LP | 1,573,357 | $20,580,000 | 2.93% |
| Logos Global Management LP | 850,000 | $11,118,000 | 1.37% |
| First Light Asset Management, LLC | 955,505 | $12,498,000 | 1.26% |
| GREAT POINT PARTNERS LLC | 316,256 | $4,137,000 | 1.00% |
| Rubric Capital Management LP | 877,161 | $11,473,000 | 0.58% |
| Avidity Partners Management LP | 1,798,100 | $23,519,000 | 0.48% |